Acute Myeloid Leukemia with Genetic Abnormalities

Acute Myeloid Leukemia with Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

264 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 19
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 30.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 51–65 of 65 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00077467	Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia	completed	Phase 1	36	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials
NCT00070551	GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia	completed	Phase 1	51	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials